|
|
Pancreatic Neuroendocrine Tumor (NETs) Diagnostic Testing Providing continuity of service for rare Endocrinology and Gastroenterology testing since 1969 Read more about these conclusions about ISI’s Pancreastatin assay providing valuable information for patients at high risk of recurrence and accurately detecting progression. NCAN Virtual Patient Conference The next NCAN virtual patient conference is Saturday, May 8, 2021. Click here for more information and registration instructions.
Luncheon With The Experts On November 19th, Inter Science Institute's C.O.O., Mia S. Tepper, MBA was the featured speaker on the Carcinoid Cancer Foundation “Luncheon with the Experts”. Click the link below to view the video: https://www.facebook.com/Carcinoid/videos/1496649470530262/ The Carcinoid Cancer Foundation began as the Carcinoid Tumor and Serotonin Research Foundation in 1968 when the NIH fund for rare cancers was terminated. The name was changed to the Carcinoid Cancer Foundation in 1995. It is a nonprofit organization chartered by the State of New York for the purpose of encouraging and supporting education and research on carcinoid and related neuroendocrine cancers. For more information go to: www.carcinoid.org. 5-HIAA assay is now available on plasma (Z-tubeTM) from ISI New test available for patients: the 5-HIAA assay is now available on plasma (Z-tubeTM) from ISI. Click here to see the requirements.
Just added: two new peer-reviewed published papers on Pancreastatin
ISI's Latest Journal Publications are Available To learn more about how these biomarkers are used, read the paper(s) below:
C.U.R.E.® Catalogue The C.U.R.E.® Catalogue lists over 150 individual assays, that can be performed on plasma/serum, urine, CSF, Saliva, and other fluids in the areas of: G.I. & Pancreatic Tests Please contact ISI for the most up to date testing availability.
Search Individual Assays To Search by name:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
ISI is the leader in neuroendocrine tumors (NET's) Biomarker Testing
|
|
